A New Reimbursement Law in Poland Is Forthcoming – Will It Enhance Access to Medicines?
- Published in:
- 2025
- By:
- Publication type:
- Report
Works matching IS 27513971 AND DT 2025 AND VI 8 AND IP 1
Results: 8
1
2
Supply of Investigational Medicinal Product after the Conclusion of Clinical Trials: The Times They Are A-Changin'.
- Published in:
- 2025
- By:
- Publication type:
- Report
3
From Lab to Market: The EU AI Act's Impact on Pharmaceutical AI Deployers.
- Published in:
- 2025
- By:
- Publication type:
- Report
4
Regulatory Sandbox to Support Innovation in the Pharmaceutical Field.
- Published in:
- European Health & Pharma Law Review, 2025, v. 8, n. 1, p. 28, doi. 10.21552/ehpl/2025/1/6
- By:
- Publication type:
- Article
5
How Can We End Drug Misuse by Properly Regulating Off-Label Drug Use in the EU: The Example of Fluoroquinolones?
- Published in:
- European Health & Pharma Law Review, 2025, v. 8, n. 1, p. 18, doi. 10.21552/ehpl/2025/1/5
- By:
- Publication type:
- Article
6
Public versus Private Interests in Intellectual Property Rights Law: Where does the Right to Science Stand in Cancer Research?
- Published in:
- European Health & Pharma Law Review, 2025, v. 8, n. 1, p. 3, doi. 10.21552/ehpl/2025/1/4
- By:
- Publication type:
- Article
7
Editorial.
- Published in:
- 2025
- By:
- Publication type:
- Editorial
8
EHPL 1/2025 (Vol. 8).
- Published in:
- European Health & Pharma Law Review, 2025, v. 8, n. 1, p. 1
- Publication type:
- Article